Skip to content

Author

Emre Aydın

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Finerenone Use in Heart Failure Patients with Type 2 Diabetes and Kidney Disease: An Analysis of the FINE-TURK Registry.

BACKGROUND Finerenone, a non-steroidal mineralocorticoid receptor antagonist, improves cardiorenal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease. However, real-world data on its use in patients with concomitant heart failure remain limited. This study aimed to evaluate the baseline chara...

Serap Yadigar, Suat Akgür, T. Güvenç et al. · 0 citations
Aug 2026

Controlling Nutritional Status Score and Early Posttransplant Outcomes: Infection Risk and Acute Rejection in Kidney Transplant Recipients.

The CONUT score may serve as a simple and practical tool for infection and BPAR risk stratification in routine clinical practice and may be an independent predictor of early serious infection after kidney transplantation.

Muhammed Emre Sevim, Emre Aydın, Pelda Zümrüt Sevim et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.